AVBP
ArriVent BioPharma, Inc. Common StockNASDAQHealthcare$24.89+2.77%ClosedMarket Cap: $1.10B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
5
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Wed Feb 04 | LaChapelle Robin | officer: Chief Operating Officer | Sell | 130,000 | $22.67 | 130,000 |
| Wed Feb 04 | Lutzker Stuart | director, officer: President of R&D | Sell | 150,000 | $22.67 | 150,000 |
| Wed Feb 04 | Kung Winston | officer: Chief Financial Officer | Sell | 140,000 | $22.67 | 140,000 |
| Wed Feb 04 | Yao Zhengbin | director, officer: President and CEO | Sell | 550,000 | $22.67 | 550,000 |
| Wed Feb 04 | Kastenmayer James Paul | officer: General Counsel | Sell | 130,000 | $22.67 | 130,000 |
| Tue Feb 03 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10 percent owner | Sell | 555,555 | $23.37 | 3,929,117 |
| Tue Jul 15 | LaChapelle Robin | officer: Chief Operating Officer | Sell | 6,503 | $2.28 | 135,736 |
| Tue Jul 15 | LaChapelle Robin | officer: Chief Operating Officer | Sell | 2,600 | $2.28 | 129,233 |
| Tue Jul 15 | LaChapelle Robin | officer: Chief Operating Officer | Sell | 2,050 | $2.28 | 126,633 |